NexImmune, Inc.
NEXI
$0.0001
$0.000.00%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -25.33% | -25.74% | -19.50% | -9.15% | -13.24% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -65.68% | -61.77% | -53.74% | -26.91% | -19.82% |
| Operating Income | 65.68% | 61.77% | 53.74% | 26.91% | 19.82% |
| Income Before Tax | 57.71% | 54.68% | 48.25% | 28.23% | 20.15% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 57.71% | 54.68% | 48.25% | 28.23% | 20.15% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 57.71% | 54.68% | 48.25% | 28.23% | 20.15% |
| EBIT | 65.68% | 61.77% | 53.74% | 26.91% | 19.82% |
| EBITDA | 66.34% | 62.62% | 54.65% | 27.49% | 20.31% |
| EPS Basic | 61.02% | 58.19% | 52.55% | 36.29% | 28.84% |
| Normalized Basic EPS | 69.71% | 64.38% | 58.17% | 36.29% | 29.82% |
| EPS Diluted | 61.02% | 58.19% | 52.55% | 36.29% | 28.84% |
| Normalized Diluted EPS | 69.71% | 64.38% | 58.17% | 36.29% | 29.82% |
| Average Basic Shares Outstanding | 15.48% | 10.73% | 9.07% | 12.48% | 12.69% |
| Average Diluted Shares Outstanding | 15.48% | 10.73% | 9.07% | 12.48% | 12.69% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
